Oxis International, Inc. is the premier source for research products targeting biomarkers of oxidative stress. Our research products provide tools for scientists studying oxidative, antioxidant, nitrosative, and inflammatory biomarkers thought to play a central role in many human diseases such as Cancer, Diabetes, Cardiovascular, and Neurobiology disorders. In addition to our oxidative stress research products, Oxis has also developed a potent antioxidant (Ergothioneine) and a portfolio of therapeutic compounds.
Oxis International Receives $1 million Up-Front Payment from Licensing Deal with Synvista Therapeutics More…
OXIS International Files SEC form 10QSB, Quarterly Report More…
NEW, IMPROVED MPO ELISA, CATALOG # BC1129. Oxis is pleased to be introducing a new, improved ELISA for the detection of Myeloperoxidase (MPO) in heparinized plasma or serum. The new MPO ELISA has improved precision and linearity. Learn More…..
